Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20+, B-cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00720135
What this trial is testing

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+11 more
City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00880815
What this trial is testing

Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

Who this might be right for
CD20 PositiveChronic Lymphocytic LeukemiaFollicular Lymphoma+4 more
M.D. Anderson Cancer Center 60
Early research (Phase 1)Ended earlyNCT00036855
What this trial is testing

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaPost-transplant Lymphoproliferative Disorder+4 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Looking for participantsNCT07073833
What this trial is testing

The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Imbioray (Hangzhou) Biomedicine Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00989586
What this trial is testing

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Beth Christian 35
Large-scale testing (Phase 3)Study completedNCT02867566
What this trial is testing

A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Who this might be right for
Diffuse, Large B-Cell, Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 420
Large-scale testing (Phase 3)Active Not RecruitingNCT05100862
What this trial is testing

Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Who this might be right for
Relapsed/Refractory Follicular LymphomaMarginal Zone Lymphoma
BeOne Medicines 799
Early research (Phase 1)Looking for participantsNCT05418088
What this trial is testing

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Prolymphocytic Leukemia+15 more
Sumithira Vasu 54
Testing effectiveness (Phase 2)UnknownNCT05771883
What this trial is testing

A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 102
Testing effectiveness (Phase 2)Study completedNCT03485118
What this trial is testing

RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Zhejiang Hisun Pharmaceutical Co. Ltd. 137
Not applicableLooking for participantsNCT05618041
What this trial is testing

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphomaMultiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01054781
What this trial is testing

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Samsung Medical Center 91
Large-scale testing (Phase 3)Ended earlyNCT00169169
What this trial is testing

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
CD20-Positive Large B-Cell Lymphoma
Lymphoma Study Association 430
Large-scale testing (Phase 3)Study completedNCT01649856
What this trial is testing

Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)Looking for participantsNCT07097207
What this trial is testing

Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT00397800
What this trial is testing

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Technical University of Munich 12
Early research (Phase 1)Temporarily pausedNCT04746131
What this trial is testing

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 90
Early research (Phase 1)Ended earlyNCT03670888
What this trial is testing

Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients

Who this might be right for
B Cell Lymphoma
JHL Biotech, Inc. 1
Early research (Phase 1)Study completedNCT03019666
What this trial is testing

Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more
Masonic Cancer Center, University of Minnesota 39
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Next Page